Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Althaus, DE
Hans Ludwig Althaus, Lappersdorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20100098374 | OPTOELECTRONIC COMPONENT BASED ON PREMOLD TECHNOLOGY - An optoelectronic component, arrangement and method are provided. The optoelectronic component comprises a premold casing having a mounting opening adapted for mounting an optical element, particularly a waveguide, an electromagnetic radiation source and/or detector adapted for generating and/or detecting electromagnetic radiation and being mounted in the premold casing, an electromagnetic radiation deflecting element mounted in the premold casing and adapted for deflecting electromagnetic radiation between the waveguide and the electromagnetic radiation source and/or detector, and a transparent medium filling at least a part of optical spaces within the premold casing. | 04-22-2010 |
Harald Althaus, Wetter DE
| Patent application number | Description | Published |
|---|---|---|
| 20090068679 | Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof - The invention relates to binding partners of the placental growth factor (or placenta growth factor, PIGF), especially antibodies directed against the placental growth factor, and production and use thereof. | 03-12-2009 |
| 20100081212 | ANTIBODIES FOR DETERMINING THE PROTHROMBIN FRAGMENT F2/F1+2 IN A HOMOGENEOUS IMMUNOASSAY - The present invention is in the area of coagulation analysis and relates to antibodies which bind specifically to an immune complex of prothrombin fragment F2/F1+2 and an F2/F1+2 neoepitope-specific antibody fragment, and to the preparation and the use thereof in methods for determining F2/F1+2. | 04-01-2010 |
| 20100136589 | Methods and Kits for Determining von Willebrand Factor Activity in the Absence of Ristocetin and for Determining the Activity of ADAMTS-13 Protease - Described herein are method(s), kit(s), reagent(s) and the like for determining von Willebrand factor (VWF) activity in a sample in the absence of ristocetin. | 06-03-2010 |
| 20100145009 | ANTIBODIES WHICH ARE DIRECTED AGAINST THE MARBURG I POLYMORPHISM OF FACTOR VII-ACTIVATING PROTEASE (FSAP), AND THEIR PREPARATION AND USE - The invention relates to antibodies which are directed against the FSAP Marburg I variant and to their preparation and use, in particular in therapy and diagnosis. The antibodies are characterized by the fact that they bind specifically to the FSAP MR I variant but not to the FSAP wild-type protein or other mutant variants which are characterized by amino acid substitutions at other positions in the FSAP protein. | 06-10-2010 |
Josef Althaus, Fischen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120055689 | HANDHELD POWER TOOL - A handheld power tool is disclosed. The handheld power tool has a drive oscillating along a working axis and a vibration damper. The vibration damper has a mass element suspended in a spring mechanism. The spring mechanism acts with a first spring stiffness and acts with a second spring stiffness. The first spring stiffness is different from the second spring stiffness. | 03-08-2012 |
Micael Althaus, Schoneck DE
| Patent application number | Description | Published |
|---|---|---|
| 20110086916 | INTERVAL THERAPY FOR THE TREATMENT OF TINNITUS - The present invention relates to interval and/or maintenance therapy employing 1-amino-alkylcyclohexane derivatives (e.g., neramexane or a pharmaceutically acceptable salt thereof) for the treatment of an individual afflicted with tinnitus. | 04-14-2011 |
Michael Althaus, Offenbach DE
| Patent application number | Description | Published |
|---|---|---|
| 20100190751 | NOVEL COMBINATION OF NERAMEXANE FOR TREATMENT OF NERORDEGENERATIE DISORDERS - The present invention relates to combinations comprising neramexane and a Glutamate Release Inhibitor (GRI) and the use of such combinations in the treatment of neurodegenerative disorders. | 07-29-2010 |
| 20100234358 | NERAMEXANE FOR THE TREATMENT OF NYSTAGMUS - The present invention relates to the treatment of an individual diagnosed with nystagmus comprising administering to the individual an effective amount of a 1-aminoalkylcyclohexane derivative, for example neramexane or a pharmaceutically acceptable salt thereof, such as neramexane mesylate. | 09-16-2010 |
Michael Althaus, Schoneck DE
| Patent application number | Description | Published |
|---|---|---|
| 20100298441 | TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF AN INNER EAR DISORDER - The present invention relates to a titration scheme for the administration of a 1-amino-alkylcyclohexane derivative which allows for quick attainment of an effective dose of a 1-amino-alkylcyclohexane derivative while minimizing side effects. The present invention further relates to a titration package for providing a 1-amino-alkylcyclohexane derivative (e.g., neramexane or a pharmaceutically acceptable salt thereof) in at least two different dosages. The present titration scheme/titration package may be useful in the treatment of various diseases, including tinnitus. | 11-25-2010 |
| 20110207793 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS. - The present invention relates to the treatment of an individual afflicted with sleep disorders associated with tinnitus and/or neurological diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative. | 08-25-2011 |
Michael Althaus, Schoeneck DE
| Patent application number | Description | Published |
|---|---|---|
| 20110178179 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS - The present invention relates to the treatment of an individual afflicted with cognitive impairment associated with tinnitus comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative. | 07-21-2011 |
| 20110294890 | Neramexane for the treatment or prevention of inner ear disorders - The present invention relates to a method of treatment or prevention of an inner ear disorder in a female comprising administering a therapeutically effective amount of neramexane or a pharmaceutically acceptable salt thereof to a female. | 12-01-2011 |
Stefanie Althaus, Koln DE
| Patent application number | Description | Published |
|---|---|---|
| 20100292328 | Cosmetic Compositions Containing Esters of 2-ethylbutanol - The invention relates to the use of esters of 2-ethylbutanol with C | 11-18-2010 |
Stefanie Althaus, Koeln DE
| Patent application number | Description | Published |
|---|---|---|
| 20090182046 | Cosmetic Compositions Containing Esters Based on 2-Propylheptanol - Esters of 2-propylheptanol with linear or branched, saturated or unsaturated C | 07-16-2009 |